전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Review


References

  1. Cortesia C, Vilchèze C, Bernut A, Contreras W, Gómez K, de Waard J, et al. 2014. Acetic Acid, the active component of vinegar, is an effective tuberculocidal disinfectant. mBio 5: e00013-14.
    Pubmed PMC
  2. Fraise AP, Wilkinson MA, Bradley CR, Oppenheim B, Moiemen N. 2013. The antibacterial activity and stability of acetic acid. J. Hosp. Infect. 84: 329-331.
    Pubmed
  3. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, et al. 2012. Diversity of bifidobacteria within the infant gut microbiota. PLoS One 7: e36957.
    Pubmed PMC
  4. Mitsou EK, Kirtzalidou E, Oikonomou I, Liosis G, Kyriacou A. 2008. Fecal microflora of Greek healthy neonates. Anaerobe 14: 94101.
    Pubmed
  5. Balakrishnan RS. 2007. The normal bacterial flora of the human intestine and its regulation. J. Clin. Gastroenterol. 41: S2-S6
  6. DuPont AW, DuPont HL. 2011. The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. Hepatol. 8: 523531.
    Pubmed
  7. Inturri R, Stivala A, Furneri PM, Blandino G. 2016. Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination. Eur. Rev. Med. Pharmacol. Sci. 20:4943-4949.
  8. Lee DK, Park SY, An HM, Kim JR, Kim MJ, Lee SW, et al. 2011. Antimicrobial activity of Bifidobacterium spp. isolated from healthy adult Koreans against cariogenic microflora. Arch. Oral Biol. 56: 1047-1054.
    Pubmed
  9. Lee DK, Kim MJ, Ham JW, An HM, Cha MK, Lee SW, et al. 2012. In vitro evaluation of antibacterial activities and anti-inflammatory effects of Bifidobacterium spp. addressing acne vulgaris. Arch. Pharm. Res. 35: 1065-1071.
    Pubmed
  10. Muñoz-Quezada S, Chenoll E, Vieites JM, Genovés S, Maldonado J, Bermúdez-Brito M, et al. 2013. Isolation, identification and characterisation of three novel probiotic strains (Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036) from the faeces of exclusively breast-fed infants. Br. J. Nutr. 109: S51-S62
    Pubmed
  11. Abdelhamid AG, Esaam A, Hazaa MM. 2018. Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli. Saudi Pharm. J. 26: 603-607.
    Pubmed PMC
  12. Yoon JH, Kim YA, Song MS, Kang BY, Ha NJ. 2006. Lactic acid bacteria isolated from healthy Korean having antimicrobial activity against VISA and VRE. Yakhak Hoeji 50: 78-83.
  13. Lkhagvadorj E, Nagata S, Wada M, Bian L, Wang C, Chiba Y, et al. 2010. Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection. Microbiol. Immunol. 54: 265-275.
    Pubmed
  14. Yang J, Yang H. 2018. Effect of Bifidobacterium breve in combination with different antibiotics on Clostridium difficile. Front. Microbiol. 9: 2953.
    Pubmed PMC
  15. Toscano M, De Grandi R, Stronati L, De Vecchi E, Drago L. 2017. Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: a preliminary study. World J. Gastroenterol. 23:2696-2704.
    Pubmed PMC
  16. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. 2003. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 9: 565-572.
    Pubmed PMC
  17. Gagnon M, Vimont A, Darveau A, Fliss I, Jean J. 2016. Study of the ability of bifidobacteria of human origin to prevent and treat rotavirus infection using colonic cell and mouse models. PLoS One 11: e0164512.
    Pubmed PMC
  18. Ishizuka T, Kanmani P, Kobayashi H, Miyazaki A, Soma J, Suda Y, et al. 2016. Immunobiotic bifidobacteria strains modulate rotavirus immune response in porcine intestinal epitheliocytes via pattern recognition receptor signaling. PLoS One 11: e0152416.
    Pubmed PMC
  19. Vlasova AN, Chattha KS, Kandasamy S, Liu Z, Esseili M, Shao L, et al. 2013. Lactobacilli and bifidobacteria promote immune homeostasis by modulating innate immune responses to human rotavirus in neonatal gnotobiotic pigs. PLoS One 8: e76962.
    Pubmed PMC
  20. Muñoz JA, Chenoll E, Casinos B, Bataller E, Ramón D, Genovés S, et al. 2011. Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections. Appl. Environ. Microbiol. 77: 8775-8783.
    Pubmed PMC
  21. Holscher HD, Czerkies LA, Cekola P, Litov R, Benbow M, Santema S, et al. 2012. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-Blind, controlled trial. J. Parenter. Enteral. Nutr. 36: 106S-117S.
    Pubmed
  22. Wang LQ, Zhao F, Liu F, Meng XC. 2013. Live/dead state is not the factor influencing adhesion ability of Bifidobacterium animalis KLDS2.0603. J. Microbiol. 51: 584-589.
    Pubmed
  23. Natividad JM, Hayes CL, Motta JP, Jury J, Galipeau HJ, Philip V, et al. 2013. Differential induction of antimicrobial REGIII by the intestinal microbiota and Bifidobacterium breve NCC2950. Appl. Environ. Microbiol. 79: 7745-7754.
    Pubmed PMC
  24. El Kfoury KA, Romond MB, Scuotto A, Alidjinou EK, Dabboussi F, Hamze M, et al. 2017. Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro. Int. J. Antimicrob. Agents 50: 177-185.
    Pubmed
  25. Fernandez-Duarte KP, Olaya-Galán NN, Salas-Cárdenas SP, Lopez-Rozo J, Gutierrez-Fernandez MF. 2018. Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): probiotics able to block the in vitro adherence of rotavirus in MA104 cells. Probiotics Antimicrob. Proteins 10: 56-63.
    Pubmed PMC
  26. Lee A, Lee YJ, Yoo HJ, Kim M, Chang Y, Lee DS, et al. 2017. Consumption of dairy yogurt containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and heat-treated Lactobacillus plantarum improves immune function including natural killer cell activity. Nutrients 9: 558.
    Pubmed PMC
  27. Han S, Cho K, Lee CK, Song Y, Park SH, Ha NJ, et al. 2005. Enhancement of antigen presentation capability of dendritic cells and activation of macrophages by the components of Bifidobacterium pseudocatenulatum SPM 1204. J. Appl. Pharmacol. 13: 174-180.
  28. Nakamura Y, Terahara M, Iwamoto T, Yamada K, Asano M, Kakuta S, et al. 2012. Upregulation of polymeric immunoglobulin receptor expression by the heat-inactivated potential probiotic Bifidobacterium bifidum OLB6378 in a mouse intestinal explant model. Scand. J. Immunol. 75: 176-183.
    Pubmed
  29. Chae JM, Heo W, Cho HT, Lee DH, Kim JH, Rhee MS, et al. 2018. Effects of orally-administered Bifidobacterium animalis subsp. lactis strain BB12 on dextran sodium sulfate-induced colitis in mice. J. Microbiol. Biotechnol. 28: 1800-1805.
    Pubmed
  30. Khokhlova EV, Smeianov VV, Efimov BA, Kafarskaia LI, Pavlova SI, Shkoporov AN. 2012. Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol. Immunol. 56: 27-39.
    Pubmed
  31. Rodes L, Khan A, Paul A, Coussa-Charley M, Marinescu D, Tomaro-Duchesneau C, et al. 2013. Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. J. Microbiol. Biotechnol. 23: 518-526.
    Pubmed
  32. Sheikhi A, Shakerian M, Giti H, Baghaeifar M, Jafarzadeh A, Ghaed V, et al. 2016. Probiotic yogurt culture Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5 modulate the cytokine secretion by peripheral blood mononuclear cells from patients with ulcerative colitis. Drug Res. (Stuttg) 66: 300-305.
    Pubmed
  33. Silva AKS, Silva TRN, Nicoli JR, Vasquez-Pinto LMC, Martins FS. 2018. In vitro evaluation of antagonism, modulation of cytokines and extracellular matrix proteins by Bifidobacterium strains. Lett. Appl. Microbiol. 67: 497-505.
    Pubmed
  34. Vieira AT, Rocha VM, Tavares L, Garcia CC, Teixeira MM, Oliveira SC, et al. 2016. Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A. Microbes Infect. 18: 180-189.
    Pubmed

Related articles in JMB

More Related Articles